Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

Sanne J de Haart; Lisa Holthof; Willy A Noort; Monique C Minnema; Maarten E Emmelot; Tineke Aarts-Riemens; Parul Doshi; Kate Sasser; Huipin Yuan; Joost de Bruijn; Anton C M Martens; Niels W C J van de Donk; Henk M Lokhorst; Richard W J Groen; Tuna Mutis

doi:10.3324/haematol.2015.139667

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

Sanne J de Haart, Lisa Holthof, Willy A Noort, Monique C Minnema, Maarten E Emmelot, Tineke Aarts-Riemens, Parul Doshi, Kate Sasser, Huipin Yuan, Joost de Bruijn, Anton C M Martens, Niels W C J van de Donk, Henk M Lokhorst, Richard W J Groen, Tuna Mutis

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	e339-e342
Journal	Haematologica
Volume	101
Issue number	8
DOIs	https://doi.org/10.3324/haematol.2015.139667
Publication status	Published - Aug 2016

Access to Document

10.3324/haematol.2015.139667

e339.fullFinal published version, 1.07 MB

Cite this

de Haart, S. J., Holthof, L., Noort, W. A., Minnema, M. C., Emmelot, M. E., Aarts-Riemens, T., Doshi, P., Sasser, K., Yuan, H., de Bruijn, J., Martens, A. C. M., van de Donk, N. W. C. J., Lokhorst, H. M., Groen, R. W. J., & Mutis, T. (2016). Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance. Haematologica, 101(8), e339-e342. https://doi.org/10.3324/haematol.2015.139667

@article{6e8604fe79304e8a86f50a351d5c8014,

title = "Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance",

author = "{de Haart}, {Sanne J} and Lisa Holthof and Noort, {Willy A} and Minnema, {Monique C} and Emmelot, {Maarten E} and Tineke Aarts-Riemens and Parul Doshi and Kate Sasser and Huipin Yuan and {de Bruijn}, Joost and Martens, {Anton C M} and {van de Donk}, {Niels W C J} and Lokhorst, {Henk M} and Groen, {Richard W J} and Tuna Mutis",

year = "2016",

month = aug,

doi = "10.3324/haematol.2015.139667",

language = "English",

volume = "101",

pages = "e339--e342",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "8",

}

de Haart, SJ, Holthof, L, Noort, WA, Minnema, MC, Emmelot, ME, Aarts-Riemens, T, Doshi, P, Sasser, K, Yuan, H, de Bruijn, J, Martens, ACM, van de Donk, NWCJ, Lokhorst, HM, Groen, RWJ & Mutis, T 2016, 'Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance', Haematologica, vol. 101, no. 8, pp. e339-e342. https://doi.org/10.3324/haematol.2015.139667

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance. / de Haart, Sanne J; Holthof, Lisa; Noort, Willy A et al.
In: Haematologica, Vol. 101, No. 8, 08.2016, p. e339-e342.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

AU - de Haart, Sanne J

AU - Holthof, Lisa

AU - Noort, Willy A

AU - Minnema, Monique C

AU - Emmelot, Maarten E

AU - Aarts-Riemens, Tineke

AU - Doshi, Parul

AU - Sasser, Kate

AU - Yuan, Huipin

AU - de Bruijn, Joost

AU - Martens, Anton C M

AU - van de Donk, Niels W C J

AU - Lokhorst, Henk M

AU - Groen, Richard W J

AU - Mutis, Tuna

PY - 2016/8

Y1 - 2016/8

U2 - 10.3324/haematol.2015.139667

DO - 10.3324/haematol.2015.139667

M3 - Comment/Letter to the editor

C2 - 27151995

SN - 0390-6078

VL - 101

SP - e339-e342

JO - Haematologica

JF - Haematologica

IS - 8

ER -